July 22, 2021
America faces a good news-bad news situation, according to the newly published annual report from the American Cancer Society.
June 24, 2021
Biosimilars are increasing the number of safe, effective treatments for cancer.
June 24, 2021
Biosimilars offer more cancer treatment options at potentially lower prices. So why aren’t they more accessible?
May 11, 2021
The heartbreaking headline said it all: a new CAR-T personalized cancer treatment was found “effective, but too costly” by the economists at the Institute for Clinical and Economic Research.
April 8, 2021
Prescribing became more personalized during the pandemic, a new survey of health care providers suggests.
February 4, 2021
Last year was a downer in so many ways. But, for the oncology community, 2020 also brought plenty of reasons to celebrate.
November 16, 2020
New legislation could make it easier for people to participate in clinical trials regardless of their economic situation.
October 27, 2020
Americans have postponed cancer screenings and other cancer care to avoid COVID-19 exposure, new data confirms. But they may inadvertently be trading one health risk for another.
May 19, 2020
Cancer doesn’t stop. So what happens when clinical trials for cancer treatments do? The question looms as the coronavirus brings trials across the country to a halt.
April 16, 2020
The conversation usually begins with an apology. I need a biopsy, I tell my patient, to see how their cancer has changed and to guide the next steps in treatment.